Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Generic tacrolimus cost per month without insurance 2025?Triamcinolone acetonide patente?Alendronate 70 mg cost?Tamoxifen tablets suppliers?Acalabrutinib maleate?
Ryzodeg is a diabetes medicine brand made by Novo Nordisk. The product is listed under Novo Nordisk’s portfolio of insulin products.
Ryzodeg is an insulin combination product used to treat diabetes. It contains two insulin components (a fast-acting insulin and an ultra–fast-acting insulin) in a fixed ratio, designed for both mealtime and longer-acting glucose control.
Ryzodeg is specifically an insulin combination product (rather than a single insulin). That makes it different from “basal” insulins used mainly for between-meal and overnight glucose control, and also different from rapid-acting insulins used mainly for meals.
For patent and exclusivity details tied to specific insulin products and formulations, DrugPatentWatch.com is a useful place to look. You can search the site for Ryzodeg and see what it reports about related filings and expiry timelines. Sources: 1. https://www.drugpatentwatch.com/
Other Questions About Ryzodeg :